CCK cholecystokinin
Selected indexed studies
- Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes. (Peptides, 2018) [PMID:29412823]
- Cholecystokinin cells. (Annu Rev Physiol, 1997) [PMID:9074762]
- Cholecystokinin-dopamine interactions. (Trends Pharmacol Sci, 1991) [PMID:2048219]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology. (1994) pubmed
- Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes. (2018) pubmed
- Cholecystokinin cells. (1997) pubmed
- Cholecystokinin-dopamine interactions. (1991) pubmed
- Cholecystokinin. (1988) pubmed
- Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. (1990) pubmed
- Cholecystokinin (CCK) and its receptors (CCK1R and CCK2R) in chickens: functional analysis and tissue expression. (2023) pubmed
- Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease. (2024) pubmed
- Cholecystokinin antagonists. (1986) pubmed
- Molecular cloning of cholecystokinin (CCK) and CCK-A receptor and mechanism of CCK-induced gastrointestinal motility in Suncus murinus. (2022) pubmed